The World Health Organization will release a new report on the ethical oversight of artificial intelligence in health research during a virtual launch event on 21 September 2026. The guidance arrives as AI tools spread rapidly through clinical studies and drug development, raising urgent questions about informed consent, algorithmic bias, and the capacity of oversight bodies to evaluate AI-driven protocols.
A practical framework for multiple stakeholders
The report, titled Artificial Intelligence-related Health Research: Ethics Review and Oversight, offers recommendations for researchers, ethics committees, regulators, funders, and policy-makers. It focuses on the responsible conduct of health research that uses AI, rather than on AI as a clinical tool. The webinar will include opening remarks, a summary of the report's findings, and a panel discussion with experts in research ethics.
Panelists will address several pressure points. These include the challenge of obtaining meaningful informed consent when algorithms evolve during a study, the risk of bias embedded in training data, and the need to strengthen ethics committees that may lack technical expertise in machine learning methods. A dedicated segment will examine risks specific to AI-related health research conducted in low-income settings.
Access and registration details
A news update will be published on the WHO news page at 10:00 CEST on 21 September 2026. Journalists who want early access to the report or additional background can contact mediainquiries@who.int. Registration for the webinar is open now on the WHO event page.
Why this matters for healthcare, research, and government professionals
For ethics committee members and research regulators, the report signals that existing review frameworks - built around drug trials and conventional observational studies - need updating for AI protocols. Researchers designing AI-enabled studies should expect tighter scrutiny of data provenance and model transparency. Policy-makers in low-resource health systems will find concrete guidance on governance gaps that could otherwise delay or derail international research partnerships. Funders who back AI health projects will likely face pressure to require the ethical safeguards this report outlines.
Your membership also unlocks:
